BLASETTI FANTAUZZI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.135
EU - Europa 347
AS - Asia 249
AF - Africa 38
SA - Sud America 10
Totale 1.779
Nazione #
US - Stati Uniti d'America 1.121
SE - Svezia 127
IT - Italia 92
SG - Singapore 83
IN - India 68
CN - Cina 56
TG - Togo 35
FI - Finlandia 27
TR - Turchia 27
DE - Germania 25
CA - Canada 14
UA - Ucraina 13
RO - Romania 12
GB - Regno Unito 11
IE - Irlanda 10
AR - Argentina 9
ID - Indonesia 8
RU - Federazione Russa 8
BE - Belgio 6
BG - Bulgaria 3
GR - Grecia 3
NL - Olanda 3
AT - Austria 2
ES - Italia 2
MY - Malesia 2
NG - Nigeria 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
FR - Francia 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
PL - Polonia 1
SC - Seychelles 1
TW - Taiwan 1
Totale 1.779
Città #
Fairfield 171
Woodbridge 75
Ashburn 71
Chandler 68
Dearborn 66
Seattle 65
Ann Arbor 59
Singapore 58
Houston 56
Cambridge 53
Wilmington 53
Princeton 42
Santa Clara 40
Lomé 35
Plano 34
Istanbul 27
Millbury 23
Beijing 22
Rome 21
Boston 16
Lawrence 14
San Paolo di Civitate 13
San Diego 12
Dublin 11
Genova 11
Federal 9
Andover 8
Jakarta 8
Toronto 8
Kunming 7
Brussels 6
Cagliari 6
Nanjing 6
New York 6
Norwalk 6
Ottawa 6
London 5
Moscow 5
Frankfurt am Main 4
Hefei 4
Hyderabad 4
Mannheim 4
Palermo 4
Phoenix 4
Boardman 3
Bremen 3
Falkenstein 3
Falls Church 3
Grafing 3
Sofia 3
Zhengzhou 3
Abuja 2
Bühl 2
Catania 2
Guangzhou 2
Jacksonville 2
Kuala Lumpur 2
Lugones 2
Noto 2
Redwood City 2
Turin 2
Vienna 2
Xian 2
Americana 1
Block 1
Colle Brianza 1
Cormeilles-en-Parisis 1
Denver 1
Dubai 1
Edinburgh 1
Ferrara 1
Genoa 1
Helsinki 1
Jönköping 1
Leawood 1
Los Angeles 1
Milan 1
Modena 1
Nanchang 1
Nanning 1
Naples 1
Narashino 1
New Delhi 1
Ningbo 1
Polska 1
Prineville 1
Redmond 1
San Mateo 1
Southend 1
Taipei 1
Trumbull 1
Wenzhou 1
Ürümqi 1
Totale 1.301
Nome #
D-carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation 97
The advanced glycation endproduct Nε-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention 92
Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice 90
Deficiency of the purinergic receptor 2X7 attenuates nonalcoholic steatohepatitis induced by high-fat diet. possible role of the NLRP3 Inflammasome 85
FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice 85
Galectin-3 ablation protects mice from diet-induced NASH. A major scavenging role for galectin-3 in liver 85
Attivazione del sistema prorenina/renina nella nefropatia diabetica sperimentale 81
The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis 78
Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester. effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice 75
L-carnosine and its derivatives as new therapeutic agents for the prevention and treatment of vascular complications of diabetes 75
Role of Galectin-3 in Obesity and Impaired Glucose Homeostasis 72
Galectin-3 in diabetic patients 71
La D-carnosina previene la nefropatia diabetica nel topo db/db. 69
Metabolically healthy versus metabolically unhealthy obesity 69
Role of galectin-3 in bone cell differentiation, bone pathophysiology and vascular osteogenesis 66
The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: Possible role of NLRP3 inflammasome activation 59
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis 58
La D-carnosina attenua lo sviluppo di aterosclerosi e malattia renale nel topo ApoE null a dieta grassa. 56
Activation of the prorenin/renin system in experimental diabetic nephropathy 43
L’ablazione del recettore purinergico p2x7 attenua il danno renale indotto dalla dieta grassa iducendo l'attivazione dell'inflammasoma NLRP3. 43
D-carnosine prevents diabetic nephropathy in db/db mice 42
D-carnosine prevents diabetic nephropathy in db/db mice 41
Diabetes and pancreatic cancer: role of advanced glycation endproducts (AGEs) in tumor progression via RAGE activation 41
Effetto dell'alto glucosio su espressione e processamento del recettore della (pro)renina in cellule mesangiali 38
Il deficit del recettore P2X7 attenua la steato-epatite non alcolica (NASH) indotta dalla dieta grassa: possibile ruolo dell’inflammasoma NLRP3 34
La diade galectina-3/rage regola la calcificazione vascolare 29
Espressione e localizzazione di galectina-3 in placche carotidee umane: possibile ruolo nel processo osteogenico aterosclerotico. 28
Il trattamento con octyl-D-carnosina protegge dall’aterosclerosi e dal danno renale indotto dal diabete: evidenze a favore di un ruolo degli AGE nel fenomeno del “legacy effect” 28
Protection from diabetes-induced atherosclerosis and renal disease by Octyl-D-carnosine: evidences for a role of AGEs in hyperclycaemic memory 24
Role of purinergic receptor 2X7 in renal disease and non-alcoholic steatohepatitis (NASH) associated with metabolic disorders through activation of the NLRP3 inflammasome 23
Octyl-D-carnosine attenuates atherosclerosis and renal disease in ApoE null mice fed a western diet. 23
Ruolo di galectina-3 nel rimodellamento osseo: possibili relazioni tra fenotipo scheletrico e metabolismo glucidico 22
P2X(7) deficiency attenuates renal disease induced by high-fat diet 22
P2X7 deficiency attenuates renal disease induced by high-fat diet 22
L’ablazione del recettore P2X7 protegge dalla steato-epatite non alcolica (NASH) indotta da dieta grassa 21
Totale 1.887
Categoria #
all - tutte 5.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 0 90 61 40 35 22 17 19
2020/2021197 10 14 1 12 2 0 16 45 22 59 14 2
2021/2022299 2 16 17 23 46 7 5 29 35 22 21 76
2022/2023370 84 96 13 28 34 29 7 29 23 3 12 12
2023/2024164 12 34 4 19 16 9 4 18 3 17 6 22
2024/2025142 4 7 37 11 24 59 0 0 0 0 0 0
Totale 1.887